Anti-Allergic Drugs Market - Global Market Size, Industry Trends, Competitive Landscape, and Opportunities and Forecast 2022 - 2030
CHAPTER 1. Industry Overview of Anti-Allergic Drugs Market
1.1. Definition and Scope
1.1.1. Definition of Anti-Allergic Drugs
1.1.2. Market Segmentation
1.1.3. Years Considered for the Study
1.1.4. Assumptions and Acronyms Used
1.1.4.1. Market Assumptions and Market Forecast
1.1.4.2. Acronyms Used in Global Anti-Allergic Drugs Market
1.2. Summary
1.2.1. Executive Summary
1.2.2. Anti-Allergic Drugs Market By Type of Allergy
1.2.3. Anti-Allergic Drugs Market By Medication
1.2.4. Anti-Allergic Drugs Market By End-Users
1.2.5. Anti-Allergic Drugs Market By Regions
CHAPTER 2. Research Approach
2.1. Methodology
2.1.1. Research Programs
2.1.2. Market Size Estimation
2.1.3. Market Breakdown and Data Triangulation
2.2. Powder Sources
2.2.1. Secondary Sources
2.2.2. Primary Sources
CHAPTER 3. Market Dynamics And Competition Analysis
3.1. Market Drivers
3.1.1. Driver 1
3.1.2. Driver 2
3.2. Restraints and Challenges
3.2.1. Restraint 1
3.2.2. Restraint 2
3.3. Growth Opportunities
3.3.1. Opportunity 1
3.3.2. Opportunity 2
3.4. Porter’s Five Forces Analysis
3.4.1. Bargaining Power of Suppliers
3.4.2. Bargaining Power of Buyers
3.4.3. Threat of Substitute
3.4.4. Threat of New Entrants
3.4.5. Degree of Competition
3.5. Market Concentration Ratio and Market Maturity Analysis of Anti-Allergic Drugs Market
3.5.1. Go To Market Strategy
3.5.1.1. Introduction
3.5.1.2. Growth
3.5.1.3. Maturity
3.5.1.4. Saturation
3.5.1.5. Possible Development
3.6. Technological Roadmap for Anti-Allergic Drugs Market
3.7. Value Chain Analysis
3.7.1. List of Key Manufacturers
3.7.2. List of Customers
3.7.3. Level of Integration
3.8. Regulatory Compliance
3.9. Cost Structure Analysis
3.9.1. Price Trend of Key Raw Materials
3.9.2. Raw Material Suppliers
3.9.3. Proportion of Manufacturing Cost Structure
3.9.3.1. Raw Material Cost
3.9.3.2. Labor Cost
3.9.3.3. Manufacturing Expense
3.10. Competitive Landscape, 2021
3.10.1. Player Positioning Analysis
3.10.2. Key Strategies Adopted By Leading Players
CHAPTER 4. Manufacturing Plant Analysis
4.1. Manufacturing Plant Location and Establish Date of Major Manufacturers in 2021
4.2. R&D Status of Major Manufacturers in 2021
CHAPTER 5. Anti-Allergic Drugs Market By Type of Allergy
5.1. Introduction
5.2. Anti-Allergic Drugs Market Revenue (US$ Mn) By Type of Allergy
5.2.1. Anti-Allergic Drugs Market Revenue (US$ Mn) and Forecast By Type of Allergy, 2018-2030
5.2.2. Food Allergy
5.2.2.1. Food Allergy Market Revenue (US$ Mn) and Growth Rate (%), 2018-2030
5.2.3. Skin Allergy
5.2.3.1. Skin Allergy Market Revenue (US$ Mn) and Growth Rate (%), 2018-2030
5.2.4. Indoor and Outdoor Allergies
5.2.4.1. Indoor and Outdoor Allergies Market Revenue (US$ Mn) and Growth Rate (%), 2018-2030
5.2.5. Insect Allergy
5.2.5.1. Insect Allergy Market Revenue (US$ Mn) and Growth Rate (%), 2018-2030
5.2.6. Drug Allergies
5.2.6.1. Drug Allergies Market Revenue (US$ Mn) and Growth Rate (%), 2018-2030
5.2.7. Latex Allergy
5.2.7.1. Latex Allergy Market Revenue (US$ Mn) and Growth Rate (%), 2018-2030
5.2.8. Others
5.2.8.1. Others Market Revenue (US$ Mn) and Growth Rate (%), 2018-2030
CHAPTER 6. Anti-Allergic Drugs Market By Medication
6.1. Introduction
6.2. Anti-Allergic Drugs Market Revenue (US$ Mn) By Medication
6.2.1. Anti-Allergic Drugs Market Revenue (US$ Mn) and Forecast By Medication, 2018-2030
6.2.2. Corticosteroids
6.2.2.1. Corticosteroids Market Revenue (US$ Mn) and Growth Rate (%), 2018-2030
6.2.3. Antihistamines
6.2.3.1. Antihistamines Market Revenue (US$ Mn) and Growth Rate (%), 2018-2030
6.2.4. Epinephrine
6.2.4.1. Epinephrine Market Revenue (US$ Mn) and Growth Rate (%), 2018-2030
6.2.5. Decongestants
6.2.5.1. Decongestants Market Revenue (US$ Mn) and Growth Rate (%), 2018-2030
6.2.6. Allergen Immunotherapy
6.2.6.1. Allergen Immunotherapy Market Revenue (US$ Mn) and Growth Rate (%), 2018-2030
6.2.7. Others
6.2.7.1. Others Market Revenue (US$ Mn) and Growth Rate (%), 2018-2030
CHAPTER 7. Anti-Allergic Drugs Market By End-Users
7.1. Introduction
7.2. Anti-Allergic Drugs Market Revenue (US$ Mn) By End-Users
7.2.1. Anti-Allergic Drugs Market Revenue (US$ Mn) and Forecast By End-Users, 2018-2030
7.2.2. Hospitals
7.2.2.1. Hospitals Market Revenue (US$ Mn) and Growth Rate (%), 2018-2030
7.2.3. Clinics
7.2.3.1. Clinics Market Revenue (US$ Mn) and Growth Rate (%), 2018-2030
7.2.4. Ambulatory Clinics
7.2.4.1. Ambulatory Clinics Market Revenue (US$ Mn) and Growth Rate (%), 2018-2030
7.2.5. Others
7.2.5.1. Others Market Revenue (US$ Mn) and Growth Rate (%), 2018-2030
CHAPTER 8. North America Anti-Allergic Drugs Market By Country
8.1. North America Anti-Allergic Drugs Market Overview
8.2. U.S.
8.2.1. U.S. Anti-Allergic Drugs Market Revenue (US$ Mn) and Forecast By Type of Allergy, 2018-2030
8.2.2. U.S. Anti-Allergic Drugs Market Revenue (US$ Mn) and Forecast By Medication, 2018-2030
8.2.3. U.S. Anti-Allergic Drugs Market Revenue (US$ Mn) and Forecast By End-Users, 2018-2030
8.3. Canada
8.3.1. Canada Anti-Allergic Drugs Market Revenue (US$ Mn) and Forecast By Type of Allergy, 2018-2030
8.3.2. Canada. Anti-Allergic Drugs Market Revenue (US$ Mn) and Forecast By Medication, 2018-2030
8.3.3. Canada. Anti-Allergic Drugs Market Revenue (US$ Mn) and Forecast By End-Users, 2018-2030
8.4. North America PEST Analysis
CHAPTER 9. Europe Anti-Allergic Drugs Market By Country
9.1. Europe Anti-Allergic Drugs Market Overview
9.2. U.K.
9.2.1. U.K. Anti-Allergic Drugs Market Revenue (US$ Mn) and Forecast By Type of Allergy, 2018-2030
9.2.2. U.K. Anti-Allergic Drugs Market Revenue (US$ Mn) and Forecast By Medication, 2018-2030
9.2.3. U.K. Anti-Allergic Drugs Market Revenue (US$ Mn) and Forecast By End-Users, 2018-2030
9.3. Germany
9.3.1. Germany Anti-Allergic Drugs Market Revenue (US$ Mn) and Forecast By Type of Allergy, 2018-2030
9.3.2. Germany Anti-Allergic Drugs Market Revenue (US$ Mn) and Forecast By Medication, 2018-2030
9.3.3. Germany Anti-Allergic Drugs Market Revenue (US$ Mn) and Forecast By End-Users, 2018-2030
9.4. France
9.4.1. France Anti-Allergic Drugs Market Revenue (US$ Mn) and Forecast By Type of Allergy, 2018-2030
9.4.2. France Anti-Allergic Drugs Market Revenue (US$ Mn) and Forecast By Medication, 2018-2030
9.4.3. France Anti-Allergic Drugs Market Revenue (US$ Mn) and Forecast By End-Users, 2018-2030
9.5. Spain
9.5.1. Spain Anti-Allergic Drugs Market Revenue (US$ Mn) and Forecast By Type of Allergy, 2018-2030
9.5.2. Spain Anti-Allergic Drugs Market Revenue (US$ Mn) and Forecast By Medication, 2018-2030
9.5.3. Spain Anti-Allergic Drugs Market Revenue (US$ Mn) and Forecast By End-Users, 2018-2030
9.6. Rest of Europe
9.6.1. Rest of Europe Anti-Allergic Drugs Market Revenue (US$ Mn) and Forecast By Type of Allergy, 2018-2030
9.6.2. Rest of Europe Anti-Allergic Drugs Market Revenue (US$ Mn) and Forecast By Medication, 2018-2030
9.6.3. Rest of Europe Anti-Allergic Drugs Market Revenue (US$ Mn) and Forecast By End-Users, 2018-2030
9.7. Europe PEST Analysis
CHAPTER 10. Asia Pacific Anti-Allergic Drugs Market By Country
10.1. Asia Pacific Anti-Allergic Drugs Market Overview
10.2. China
10.2.1. China Anti-Allergic Drugs Market Revenue (US$ Mn) and Forecast By Type of Allergy, 2018-2030
10.2.2. China Anti-Allergic Drugs Market Revenue (US$ Mn) and Forecast By Medication, 2018-2030
10.2.3. China Anti-Allergic Drugs Market Revenue (US$ Mn) and Forecast By End-Users, 2018-2030
10.3. Japan
10.3.1. Japan Anti-Allergic Drugs Market Revenue (US$ Mn) and Forecast By Type of Allergy, 2018-2030
10.3.2. Japan Anti-Allergic Drugs Market Revenue (US$ Mn) and Forecast By Medication, 2018-2030
10.3.3. Japan Anti-Allergic Drugs Market Revenue (US$ Mn) and Forecast By End-Users, 2018-2030
10.4. India
10.4.1. India Anti-Allergic Drugs Market Revenue (US$ Mn) and Forecast By Type of Allergy, 2018-2030
10.4.2. India Anti-Allergic Drugs Market Revenue (US$ Mn) and Forecast By Medication, 2018-2030
10.4.3. India Anti-Allergic Drugs Market Revenue (US$ Mn) and Forecast By End-Users, 2018-2030
10.5. Australia
10.5.1. Australia Anti-Allergic Drugs Market Revenue (US$ Mn) and Forecast By Type of Allergy, 2018-2030
10.5.2. Australia Anti-Allergic Drugs Market Revenue (US$ Mn) and Forecast By Medication, 2018-2030
10.5.3. Australia Anti-Allergic Drugs Market Revenue (US$ Mn) and Forecast By End-Users, 2018-2030
10.6. South Korea
10.6.1. South Korea Anti-Allergic Drugs Market Revenue (US$ Mn) and Forecast By Type of Allergy, 2018-2030
10.6.2. South Korea Anti-Allergic Drugs Market Revenue (US$ Mn) and Forecast By Medication, 2018-2030
10.6.3. South Korea Anti-Allergic Drugs Market Revenue (US$ Mn) and Forecast By End-Users, 2018-2030
10.7. Rest of Asia-Pacific
10.7.1. Rest of Asia-Pacific Anti-Allergic Drugs Market Revenue (US$ Mn) and Forecast By Type of Allergy, 2018-2030
10.7.2. Rest of Asia-Pacific Anti-Allergic Drugs Market Revenue (US$ Mn) and Forecast By Medication, 2018-2030
10.7.3. Rest of Asia-Pacific Anti-Allergic Drugs Market Revenue (US$ Mn) and Forecast By End-Users, 2018-2030
10.8. Asia Pacific PEST Analysis
CHAPTER 11. Latin America Anti-Allergic Drugs Market By Country
11.1. Latin America Anti-Allergic Drugs Market Overview
11.2. Brazil
11.2.1. Brazil Anti-Allergic Drugs Market Revenue (US$ Mn) and Forecast By Type of Allergy, 2018-2030
11.2.2. Brazil Anti-Allergic Drugs Market Revenue (US$ Mn) and Forecast By Medication, 2018-2030
11.2.3. Brazil Anti-Allergic Drugs Market Revenue (US$ Mn) and Forecast By End-Users, 2018-2030
11.3. Mexico
11.3.1. Mexico Anti-Allergic Drugs Market Revenue (US$ Mn) and Forecast By Type of Allergy, 2018-2030
11.3.2. Mexico Anti-Allergic Drugs Market Revenue (US$ Mn) and Forecast By Medication, 2018-2030
11.3.3. Mexico Anti-Allergic Drugs Market Revenue (US$ Mn) and Forecast By End-Users, 2018-2030
11.4. Rest of Latin America
11.4.1. Rest of Latin America Anti-Allergic Drugs Market Revenue (US$ Mn) and Forecast By Type of Allergy, 2018-2030
11.4.2. Rest of Latin America Anti-Allergic Drugs Market Revenue (US$ Mn) and Forecast By Medication, 2018-2030
11.4.3. Rest of Latin America Anti-Allergic Drugs Market Revenue (US$ Mn) and Forecast By End-Users, 2018-2030
11.5. Latin America PEST Analysis
CHAPTER 12. Middle East & Africa Anti-Allergic Drugs Market By Country
12.1. Middle East & Africa Anti-Allergic Drugs Market Overview
12.2. GCC
12.2.1. GCC Anti-Allergic Drugs Market Revenue (US$ Mn) and Forecast By Type of Allergy, 2018-2030
12.2.2. GCC Anti-Allergic Drugs Market Revenue (US$ Mn) and Forecast By Medication, 2018-2030
12.2.3. GCC Anti-Allergic Drugs Market Revenue (US$ Mn) and Forecast By End-Users, 2018-2030
12.3. South Africa
12.3.1. South Africa Anti-Allergic Drugs Market Revenue (US$ Mn) and Forecast By Type of Allergy, 2018-2030
12.3.2. South Africa Anti-Allergic Drugs Market Revenue (US$ Mn) and Forecast By Medication, 2018-2030
12.3.3. South Africa Anti-Allergic Drugs Market Revenue (US$ Mn) and Forecast By End-Users, 2018-2030
12.4. Rest of Middle East & Africa
12.4.1. Rest of Middle East & Africa Anti-Allergic Drugs Market Revenue (US$ Mn) and Forecast By Type of Allergy, 2018-2030
12.4.2. Rest of Middle East & Africa Anti-Allergic Drugs Market Revenue (US$ Mn) and Forecast By Medication, 2018-2030
12.4.3. Rest of Middle East & Africa Anti-Allergic Drugs Market Revenue (US$ Mn) and Forecast By End-Users, 2018-2030
12.5. Middle East & Africa PEST Analysis
CHAPTER 13. Player Analysis Of Anti-Allergic Drugs Market
13.1. Anti-Allergic Drugs Company Share Analysis
13.2. Competition Matrix
13.2.1. Competitive Benchmarking of key players by price, presence, market share, and R&D investment
13.2.2. New Product Launches and Product Enhancements
13.2.3. Mergers And Acquisition In Global Anti-Allergic Drugs market
13.2.4. Partnership, Joint Ventures and Strategic Alliances/Sales Agreements
CHAPTER 14. Company Profile
14.1. Allergy Therapeutics
14.1.1. Company Snapshot
14.1.2. Business Overview
14.1.3. Financial Overview
14.1.3.1. Revenue (US$ Mn), 2021
14.1.3.2. Allergy Therapeutics 2021 Anti-Allergic Drugs Business Regional Distribution
14.1.4. Product/ Service Specification
14.1.5. Recent Developments & Business Strategy
14.1.6. Manufacturing Plant Footprint Analysis
14.2. Strides Pharma Science Limited
14.3. Allergan, Plc.
14.4. McNeil Consumer Healthcare
14.5. Collegium Pharmaceutical
14.6. Genentech, Inc.
14.7. Allergopharma GmbH & Co. KG.
14.8. GlaxoSmithKline plc
14.9. Johnson & Johnson
14.10. Stallergenes Greer plc